FZ4-99611-75008
2 vaccinations
4 coded responses
13 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 601 / IL
- Registered
- 2021-05-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-13
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Dose 2 — Pfizer-BioNTech
-
2021-05-05
Registered in v-safe
-
2021-05-05
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain, Gastrointestinal pain — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: The abdominal pain was the worst. Woke up overnight to intense lower intestinal cramping which subsided after about an hour.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-06
- 2021-05-08
- 2021-05-09
- 2021-05-11
- 2021-05-20
-
2021-05-27
Survey response — day 21, dose 2MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
- 2021-06-08
-
2021-06-17
Survey response — day 42, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-03
- 2021-11-04
-
2022-05-04
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold and sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-05-04
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-13 | Pfizer-BioNTech | |
| 2 | 2021-05-04 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): The abdominal pain was the worst. Woke up overnight to intense lower intestinal cramping which subsided after about an hour.
Release 8 — day 21, dose 2
Symptoms: Headaches
Release 9 — day 42, dose 2
Symptoms: Headache
Release 11 — 12 months, dose 2
Symptoms: Cold and sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | Abdominal pain | ✓ | ✓ | ✓ |
| SRO | Gastrointestinal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release